These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 6853040

  • 1. Nephrotic syndrome in Hodgkins disease.
    Walker F, O'Neill S, Carmody M, O'Dwyer WF.
    Int J Pediatr Nephrol; 1983 Mar; 4(1):39-41. PubMed ID: 6853040
    [Abstract] [Full Text] [Related]

  • 2. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
    Huisman RM, de Jong PE, de Zeeuw D, van Imhoff GW, van der Hem GK.
    Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
    [Abstract] [Full Text] [Related]

  • 3. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
    García Donaire JA, Manzanera MI, Valentín MO, Espejo B, Gutiérrez Martínez E, Praga M.
    Nefrologia; 2004 Dec; 24(2):179-82. PubMed ID: 15219093
    [Abstract] [Full Text] [Related]

  • 4. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
    Gordillo Paniagua G, Velázquez Jones L, Scovino Gudiño R, Arroyo Sierra J, Silva Sosa M, Mota Hernández F.
    Bol Med Hosp Infant Mex; 1977 Dec; 34(4):815-21. PubMed ID: 911442
    [Abstract] [Full Text] [Related]

  • 5. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 6. [A case from practice (148). 1. Hodgkin disease, nodular sclerosing, Stage Ia. 2. Status following minimal-change glomerulonephritis with nephrotic syndrome 1980--status following endoxan and prednisone therapy].
    Schneider K.
    Schweiz Rundsch Med Prax; 1989 Oct 03; 78(40):1104-6. PubMed ID: 2799178
    [No Abstract] [Full Text] [Related]

  • 7. [Nephrotic syndrome. Physiopathology, diagnosis, evaluation, treatment of lipoid nephrosis].
    Moulin B, Bouiller M, Hannedouche T.
    Rev Prat; 2000 Oct 15; 50(16):1807-16. PubMed ID: 11103135
    [No Abstract] [Full Text] [Related]

  • 8. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
    Cade R, Mars D, Privette M, Thompson R, Croker B, Peterson J, Campbell K.
    Arch Intern Med; 1986 Apr 15; 146(4):737-41. PubMed ID: 3963956
    [Abstract] [Full Text] [Related]

  • 9. Kimura disease: a case report and review of the Chinese literature.
    Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, Liu AM.
    Nephron Clin Pract; 2009 Apr 15; 111(1):c55-61. PubMed ID: 19052471
    [Abstract] [Full Text] [Related]

  • 10. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA, Lien JW, Aber GM.
    Clin Nephrol; 1979 Jan 15; 11(1):26-30. PubMed ID: 428152
    [Abstract] [Full Text] [Related]

  • 11. [Multiple sclerosis and nephrotic syndrome in minimal change disease].
    Benítez O, Magrans Ch, González B.
    Nefrologia; 2007 Jan 15; 27(6):749-51. PubMed ID: 18336106
    [Abstract] [Full Text] [Related]

  • 12. Acute renal failure of short duration in minimal lesion nephrotic syndrome of childhood.
    Steele BT, Bacheyie GS, Baumal R, Rance CP.
    Int J Pediatr Nephrol; 1982 Jun 15; 3(2):59-62. PubMed ID: 7107120
    [Abstract] [Full Text] [Related]

  • 13. [Nephrotic syndrome. Physiopathology, diagnosis, development, treatment of lipoid nephrosis].
    Chabannier MH, Modesto A, Orfila C, Suc JM.
    Rev Prat; 1996 Oct 01; 46(15):1907-15. PubMed ID: 8953847
    [No Abstract] [Full Text] [Related]

  • 14. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
    McEnery PT, Strife CF.
    Pediatr Clin North Am; 1982 Aug 01; 29(4):875-94. PubMed ID: 7050865
    [No Abstract] [Full Text] [Related]

  • 15. [Nephrotic syndrome in Hodgkin's disease].
    Miltényi Z, Keresztes K, Ujhelyi L, Kovács J, Illés A.
    Orv Hetil; 2005 Jun 19; 146(25):1357-60. PubMed ID: 16106759
    [Abstract] [Full Text] [Related]

  • 16. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO, Gbadegesin RA, Adeyemo AA, Akang EE, Arowolo FA, Abiola OA, Osinusi K.
    West Afr J Med; 1999 Jun 19; 18(3):203-6. PubMed ID: 10593158
    [Abstract] [Full Text] [Related]

  • 17. Nephrotic syndrome in association with Hodgkin's disease.
    Larson LS, Fritz RD.
    Wis Med J; 1976 Feb 19; 75(2):14-7. PubMed ID: 1258494
    [No Abstract] [Full Text] [Related]

  • 18. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 19. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S, Uncanin S, Dzemidzić J, Aganović K, Srna A, Rasić I.
    Bosn J Basic Med Sci; 2006 May 26; 6(2):16-20. PubMed ID: 16879107
    [Abstract] [Full Text] [Related]

  • 20. Spontaneously remitting minimal change nephropathy preceding a relapse of Hodgkin's disease by 19 months.
    Korzets Z, Golan E, Manor Y, Schneider M, Bernheim J.
    Clin Nephrol; 1992 Sep 26; 38(3):125-7. PubMed ID: 1395162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.